The high prevalence of the I27 mutant HBcAg18–27 epitope in Chinese HBV-infected patients and its cross-reactivity with the V27 prototype epitope
- 1 December 2007
- journal article
- Published by Elsevier in Clinical Immunology
- Vol. 125 (3) , 337-345
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Hepatitis B virus (HBV) antigen-pulsed monocyte-derived dendritic cells from HBV-associated hepatocellular carcinoma patients significantly enhance specific T cell responsesin vitroClinical and Experimental Immunology, 2006
- Acute phase HBV‐specific T cell responses associated with HBV persistence after HBV/HCV coinfection†Hepatology, 2005
- Identification of hepatitis B virus-specific CTL epitopes presented by HLA-A*2402, the most common HLA class I allele in East AsiaJournal of Hepatology, 2001
- T cell receptor usage of virus-specific CD8 cells and recognition of viral mutations during acute and persistent hepatitis B virus infectionEuropean Journal of Immunology, 2000
- Quantitative and functional analysis of core‐specific T‐helper cell and CTL activities in acute and chronic hepatitis BLiver International, 1998
- Molecular features of the hepatitis B virus nucleocapsid T-cell epitope 18-27: Interaction with HLA and T-cell receptorHepatology, 1997
- Hepatitis B virus (HBV) sequence variation of cytotoxic T lymphocyte epitopes is not common in patients with chronic HBV infection.Journal of Clinical Investigation, 1995
- Natural variants of cytotoxic epitopes are T-cell receptor antagonists for antiviral cytotoxic T cellsNature, 1994
- Prominent role of secondary anchor residues in peptide binding to HLA-A2.1 moleculesCell, 1993
- Changes at peptide residues buried in the major histocompatibility complex (MHC) class I binding cleft influence T cell recognition: a possible role for indirect conformational alterations in the MHC class I or bound peptide in determining T cell recognition.Journal of Experimental Medicine, 1993